πŸ‡ΊπŸ‡Έ FDA
Patent

US 8404862

Ligand-conjugated monomers

granted A61KA61K31/7088A61K31/713

Quick answer

US patent 8404862 (Ligand-conjugated monomers) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/7088, A61K31/713, A61K47/54, A61K47/543